• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症的正电子发射断层扫描研究:神经特征和功能衰退的脑代谢关联

PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.

作者信息

Young A B, Penney J B, Starosta-Rubinstein S, Markel D S, Berent S, Giordani B, Ehrenkaufer R, Jewett D, Hichwa R

出版信息

Ann Neurol. 1986 Sep;20(3):296-303. doi: 10.1002/ana.410200305.

DOI:10.1002/ana.410200305
PMID:2945510
Abstract

Fifteen drug-free patients with early to midstage Huntington's disease were evaluated with quantitative neurological examinations, scales for functional capacity, computed tomographic (CT) scans, and positron emission tomographic (PET) scans of 18F-2-fluoro-2-deoxyglucose (18F-FDG) uptake. All patients had abnormal indices of caudate metabolism on PET scanning, whereas in patients with early disease indices of putamen metabolism and CT measures of caudate atrophy were normal. Indices of caudate metabolism correlated highly with the patients' overall functional capacity (r = 0.906; p less than 0.001) and bradykinesia/rigidity (r = -0.692; p less than 0.01). Indices of putamen metabolism correlated highly with motor functions: chorea (r = -0.841; p less than 0.01), oculomotor abnormalities (r = -0.849; p less than 0.01), and fine motor coordination (r = -0.866; p less than 0.01). Indices of thalamic metabolism correlated positively with dystonia (r = 0.559; p less than 0.05). The data suggest that PET scanning with 18F-FDG is a sensitive measure of brain dysfunction in Huntington's disease and that basal ganglia metabolism is highly correlated with the overall functional capacity of individual patients and with the degree of their motor abnormalities.

摘要

对15名处于亨廷顿病早期至中期且未服用药物的患者进行了定量神经学检查、功能能力量表评估、计算机断层扫描(CT)以及18F-2-氟-2-脱氧葡萄糖(18F-FDG)摄取的正电子发射断层扫描(PET)。所有患者的PET扫描显示尾状核代谢指标异常,而早期疾病患者的壳核代谢指标及尾状核萎缩的CT测量结果均正常。尾状核代谢指标与患者的整体功能能力高度相关(r = 0.906;p < 0.001)以及运动迟缓/僵硬(r = -0.692;p < 0.01)。壳核代谢指标与运动功能高度相关:舞蹈症(r = -0.841;p < 0.01)、动眼神经异常(r = -0.849;p < 0.01)以及精细运动协调(r = -0.866;p < 0.01)。丘脑代谢指标与肌张力障碍呈正相关(r = 0.559;p < 0.05)。数据表明,18F-FDG的PET扫描是亨廷顿病脑功能障碍的敏感测量方法,并且基底神经节代谢与个体患者的整体功能能力及其运动异常程度高度相关。

相似文献

1
PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.亨廷顿舞蹈症的正电子发射断层扫描研究:神经特征和功能衰退的脑代谢关联
Ann Neurol. 1986 Sep;20(3):296-303. doi: 10.1002/ana.410200305.
2
Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function.亨廷顿舞蹈症的正电子发射断层扫描研究:认知功能的脑代谢相关性
Ann Neurol. 1988 Jun;23(6):541-6. doi: 10.1002/ana.410230603.
3
A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.亨廷顿舞蹈病高危人群的神经学、代谢、结构及遗传学评估比较
Ann Neurol. 1990 Nov;28(5):614-21. doi: 10.1002/ana.410280503.
4
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.无症状基因携带者和亨廷顿病患者的纹状体葡萄糖代谢及多巴胺D2受体结合情况
Brain. 1996 Dec;119 ( Pt 6):2085-95. doi: 10.1093/brain/119.6.2085.
5
Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.正电子发射断层扫描术对亨廷顿舞蹈症中苯二氮䓬受体的测量
Ann Neurol. 1993 Jul;34(1):76-81. doi: 10.1002/ana.410340114.
6
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.通过18氟脱氧葡萄糖和计算机断层扫描确定亨廷顿舞蹈症中的脑代谢与萎缩情况。
Ann Neurol. 1982 Nov;12(5):425-34. doi: 10.1002/ana.410120504.
7
Cerebral metabolism of glucose in benign hereditary chorea.良性遗传性舞蹈病中的脑葡萄糖代谢
Mov Disord. 1986;1(1):33-44. doi: 10.1002/mds.870010105.
8
Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Res Publ Assoc Res Nerv Ment Dis. 1985;63:199-209.
9
Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.亨廷顿病风险无症状受试者的脑葡萄糖代谢降低。
N Engl J Med. 1987 Feb 12;316(7):357-62. doi: 10.1056/NEJM198702123160701.
10
Positron emission tomography in the early diagnosis of Huntington's disease.正电子发射断层扫描在亨廷顿病早期诊断中的应用
Neurology. 1986 Jul;36(7):888-94. doi: 10.1212/wnl.36.7.888.

引用本文的文献

1
Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review.亨廷顿舞蹈症生物标志物的进展:十年文献计量分析与综合综述
Biology (Basel). 2025 Jan 26;14(2):129. doi: 10.3390/biology14020129.
2
Neuroimaging to Facilitate Clinical Trials in Huntington's Disease: Current Opinion from the EHDN Imaging Working Group.神经影像学在亨廷顿病临床试验中的应用:EHDN 影像学工作组的最新观点。
J Huntingtons Dis. 2024;13(2):163-199. doi: 10.3233/JHD-240016.
3
[F]FDG PET in conditions associated with hyperkinetic movement disorders and ataxia: a systematic review.
[F]FDG PET 在后天性运动障碍和共济失调相关疾病中的应用:一项系统综述。
Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):1954-1973. doi: 10.1007/s00259-023-06110-w. Epub 2023 Jan 27.
4
A New Perspective on Huntington's Disease: How a Neurological Disorder Influences the Peripheral Tissues.对亨廷顿病的新视角:神经紊乱如何影响周围组织。
Int J Mol Sci. 2022 May 29;23(11):6089. doi: 10.3390/ijms23116089.
5
Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease.用于亨廷顿舞蹈病等位基因特异性靶向的单倍型特异性插入缺失变异
Mol Ther Methods Clin Dev. 2022 Mar 4;25:84-95. doi: 10.1016/j.omtm.2022.03.001. eCollection 2022 Jun 9.
6
Metabolism in Huntington's disease: a major contributor to pathology.亨廷顿病中的代谢:病理学的主要贡献因素。
Metab Brain Dis. 2022 Aug;37(6):1757-1771. doi: 10.1007/s11011-021-00844-y. Epub 2021 Oct 27.
7
Corticostriatal Hypermetabolism in Moyamoya Disease-Induced Hemichorea: Two Case Reports and a Literature Review.烟雾病所致偏侧舞蹈症中的皮质纹状体代谢亢进:两例报告及文献综述
Front Neurol. 2021 Jun 24;12:649014. doi: 10.3389/fneur.2021.649014. eCollection 2021.
8
Glucose Metabolic Dysfunction in Neurodegenerative Diseases-New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming.神经退行性疾病中的葡萄糖代谢功能障碍——新的机制见解和缺氧作为靶向代谢重编程的潜在治疗靶点。
Int J Mol Sci. 2021 May 31;22(11):5887. doi: 10.3390/ijms22115887.
9
Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study.亨廷顿病发病延迟和进展减缓的亨廷顿基因沉默:一项生物标志物研究。
Brain. 2021 Nov 29;144(10):3101-3113. doi: 10.1093/brain/awab190.
10
Biological Aging and the Cellular Pathogenesis of Huntington's Disease.生物衰老与亨廷顿病的细胞发病机制。
J Huntingtons Dis. 2020;9(2):115-128. doi: 10.3233/JHD-200395.